4(R)-HYDROXY-6(R)-(2-(2(S)-METHYL-DECAHYDRONAPHTHYL-1(S)) ETHYL)-TETRAHYDROPYRAN-2-ONE DERIVATIVES

摘要

Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) or (II): wherein position 5 of the polyhydronaphthyl ring is singly or doubly bonded to oxygen or incorporated into a C3-7 carbocyclic ring.